DealLawyers.com Blog

November 16, 2026

Activism: Blurring the Lines Between Activism & Private Equity

Cooley recently published its 2026 Activism Retrospective. One of the topics highlighted in the publication is the increasing convergence between activist tactics and those of private equity buyers. This excerpt explains what’s going on:

Activist hedge funds and private equity firms share fundamental similarities – and the line between them has blurred, as each has adopted the other’s tactics. When a company is underperforming or misunderstood by the market, it is often seen as an opportunity for both activist engagement and private equity investment. This convergence is logical. Activists and private equity firms are ultimately value investors, and certain qualities that make a company an attractive target for activism are not dissimilar to those that might drive a go-private transaction.

Well-capitalized activists, like Carl Icahn, Elliott, Pershing Square and Trian, have demonstrated their willingness and ability to take their portfolio companies private. In some cases, activists have partnered with private equity funds to form formidable buyer consortiums. In others, they have signed the check themselves, including in multibillion-dollar transactions.

This year, activists with fewer assets under management ventured into private-equity-style go-private transactions involving their portfolio companies. This was particularly true during the first half of 2026, as the M&A market was meaningfully bifurcated. While large capitalization companies enjoyed relatively smooth dealmaking terrain, the middle market was less active. As a result, activists attempted to nudge their smaller portfolio companies into dealmaking – at times, coupling traditional activist tactics, such as public pressure campaigns and proxy contests, with proposals to acquire their target.

The publication also addresses the evolving role of AI-related issues in activist strategies, and the increasing use of informal settlements. It also comments on what to expect in 2027, and the excerpt addresses the role that M&A demands are expected to play next year:

Where activists and companies cannot find alignment, we expect M&A theses to be both prevalent and a key point of divergence between investors and issuers. While ever an important play on the activist call sheet, the M&A push stands to be escalated at smaller companies that have watched their larger competitors continue to grow and have suffered from a selective private equity industry that spent 2026 writing larger tickets on a more targeted transaction profile. In addition, if sponsors continue to sit on dry powder, more activists might explore putting their capital to work in the private equity mold, including with the hope of drawing private equity firms off the sidelines.

– John Jenkins

Take Me Back to the Main Blog Page

Blog Preferences: Subscribe, unsubscribe, or change the frequency of email notifications for this blog.

UPDATE EMAIL PREFERENCES

Try Out The Full Member Experience: Not a member of DealLawyers.com? Start a free trial to explore the benefits of membership.

START MY FREE TRIAL